CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Biotechnologies Ltd. on July 7, 2026, for the month of July 2026. The filing serves to notify shareholders of an upcoming Extraordinary General Meeting scheduled for July 29, 2026, at the offices of Goldfarb Gross Seligman & Co. in Tel-Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The primary event is the scheduling of a corporate governance meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks. It references the attached Notice and Proxy Statement (Exhibit 99.1) for details on the proposal to be voted upon at the General Meeting.
Key Facts for Investors
- Meeting Date: July 29, 2026, at 10:00 a.m. Israel time.
- Location: Goldfarb Gross Seligman & Co., One Azrieli Center, Tel-Aviv, Israel.
- Documentation: The Notice and Proxy Statement (Exhibit 99.1) and Proxy Card (Exhibit 99.2) are attached to this filing.
- Financial Data: No financial results are included in this specific filing.